SCHEMBL10975136

SCHEMBL10975136

CC(O)NC(=O)C=Cc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.71
ALDH1A1 P00352 3/20 0.61
CYP1A2 P05177 2/20 0.61
CYP2C9 P11712 2/20 0.61
CYP3A4 P08684 1/20 0.61
MAPK1 P28482 1/20 0.61
CYP2C19 P33261 1/20 0.61
HDAC3 O15379 2/20 0.61
HDAC4 P56524 2/20 0.61
HDAC1 Q13547 2/20 0.61
HDAC2 Q92769 2/20 0.61
HDAC8 Q9BY41 2/20 0.61
HDAC6 Q9UBN7 2/20 0.61
LMNA P02545 2/20 0.57
EGFR P00533 5/20 0.57
MMP1 P03956 4/20 0.56
MMP2 P08253 4/20 0.56
MMP9 P14780 4/20 0.56
MAOA P21397 1/20 0.56
MAOB P27338 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10975112 1.00 TDP1 (0.71) TDP1ALDH1A1CYP1A2CYP2C9CYP3A4
N-Isopropylcinnamamide SCHEMBL6751570 0.87 TDP1 (0.73) TDP1ALDH1A1CYP1A2CYP2C9CYP3A4
N-Isopropylcinnamamide SCHEMBL6751573 0.87 TDP1 (0.73) TDP1ALDH1A1CYP1A2CYP2C9CYP3A4
SCHEMBL1557349 0.84 SMN1; SMN2 (0.70) TDP1ALDH1A1CYP1A2CYP2C9CYP3A4
SCHEMBL1558184 0.84 SMN1; SMN2 (0.70) TDP1ALDH1A1CYP1A2CYP2C9CYP3A4
SCHEMBL22994501 0.84 SMN1; SMN2 (0.70) TDP1ALDH1A1CYP1A2CYP2C9CYP3A4
SCHEMBL28253673 0.84 SMN1; SMN2 (0.70) TDP1ALDH1A1CYP1A2CYP2C9CYP3A4
SCHEMBL1557347 0.84 SMN1; SMN2 (0.70) TDP1ALDH1A1CYP1A2CYP2C9CYP3A4
SCHEMBL1558185 0.84 SMN1; SMN2 (0.70) TDP1ALDH1A1CYP1A2CYP2C9CYP3A4
N-Isopropylcinnamamide SCHEMBL3963268 0.84 TDP1 (0.69) TDP1ALDH1A1CYP1A2CYP2C9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0094283-B1 SUSTAINED-RELEASE THEOPHYLLIN DRUG FORMULATION LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1985-11-21 EP disclosed
EP-0094283-A1 Sustained-release theophyllin drug formulation LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1983-11-16 EP disclosed